Randomized clinical trial: comparison between Histidine-tryptophan-ketoglutarate cardioplegia and cold blood cardioplegia for myocardial protection for Fallot tetralogy patients undergoing total repair This study aims to compare HTK cardioplegic solution and cold blood cardioplegia to provide optimal myocardial protection for a patient with tetralogy of Fallot planned for total repair.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
52
will receive HTK cardioplegia in volume 30 ml/Kg given by antegrade route through an aortic route cannula.
as the will receive group cold Blood Cardioplegia in volume 20mL/kg given by antegrade route through an aortic route cannula and repeated 10mL/kg/dose every 25minutes at 8-12°C for maintenance. This technique considered the standard management in this age.
Samar Soliman
Cairo, Nasr City, Egypt
RECRUITING• Vasoactive-Inotropic Score
Calculate the doses of vasoactive drugs used
Time frame: From time of separation of cardioplumonary bypass till 24 hours post operative
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.